PFE News 29.21 08/27/2014 05:31:45 Pfizer Inc (PFE)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Pfizer Inc (PFE) 29.21 $PFE

How the Rising Dollar May Impact Your Portfolio - Stocks in the News
Zacks Research Staff - Zacks Investment Research - Tue Aug 26, 8:03PM CDT
These companies could be impacted if the dollar continues to rise.

Merck, Pfizer combining drugs
at Investor's Business Daily - Tue Aug 26, 5:45PM CDT
Merck (MRK) will study its new immunotherapy drug candidate, brolizumab, in combination with Pfizer's (PFE) already-approved Xalkori to treat metastatic lung cancer. The trial is expected to start next year. In Feb. the drug giants announced they...

Most active New York Stock Exchange-traded stocks
AP - Tue Aug 26, 5:05PM CDT
NEW YORK (AP) — A look at New York Stock Exchange 10 most-active stocks at the close of trading:

Final Glance: Pharmaceuticals companies
AP - Tue Aug 26, 5:05PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies were mixed at the close of trading:

HCP Boasts Of 29 Years Of Dividend Increases
at Investor's Business Daily - Tue Aug 26, 4:57PM CDT
HCP (HCP) is a real estate investment trust that invests in four health-care sectors: senior housing; post-acute/skilled nursing facilities; life sciences; and medical offices and hospitals. The company manages, acquires, develops and sells...

After Yesterday's Rally of 1.04% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Tue Aug 26, 3:42PM CDT
Pfizer (NYSE FE) traded in a range yesterday that spanned from a low of $28.96 to a high of $29.31. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $29.09 on volume of 16.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Pfizer Rises 1.04% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Tue Aug 26, 3:41PM CDT
Pfizer (NYSE FE) traded in a range yesterday that spanned from a low of $28.96 to a high of $29.31. Yesterday, the shares gained 1.0%, which took the trading range above the 3-day high of $29.09 on volume of 16.7 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.

Economic Data Fuel Another All-Time High For S&P 500
at Investor's Business Daily - Tue Aug 26, 2:36PM CDT
A big jump in durable goods orders and a strong reading on consumer confidence from the Conference Board fueled modest gains for the stock market Tuesday. The Dow Jones industrial average led the way, rising 0.3%. Exxon Mobil (XOM), UnitedHealth...

Why Merck (MRK) Stock Is Gaining Today
at The Street - Tue Aug 26, 2:14PM CDT
Merck (MRK) shares are climbing after the company revealed a collaborative effort with Pfizer on lung cancer treatment trials.

Ethical Pharmaceuticals Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020
PRWeb - Tue Aug 26, 1:03PM CDT
Ethical pharmaceuticals or prescription drugs are those licensed drugs that are regulated by various legislation to require a written medical prescription before it can be procured. An ethical pharmaceutical product is only sold by pharmacists when it has been approved by a written medical prescription from a registered medical practitioner. The term prescription drugs or ethical pharmaceutical is usually used to distinguish the products from over-the-counter drugs--drugs that can be obtained without a written medical prescription. However, varied jurisdictions have varied definitions of what constitutes an ethical pharmaceutical. At present, ethical pharmaceuticals market is highly profitable as well as a risky market venture. The market is expected to be profitable owing to the upcoming patent expiries of many blockbuster drugs; and risky because of the involvement of many established and multinational companies who have built a global recognition for their safe and effective products.

Midday Glance: Pharmaceuticals companies
AP - Tue Aug 26, 12:31PM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 1 p.m.:

Merck, Pfizer Combining Drugs In Lung Cancer Study
at Investor's Business Daily - Tue Aug 26, 11:07AM CDT
Big pharma Merck (MRK) will study its hot new immunotherapy drug candidate in combination with rival Pfizer's currently approved Xalkori to treat metastatic lung cancer, the two firms announced Tuesday. The trial of pembrolizumab and Xalkori,...

Should Gilead Sciences, inc. Fear This New Competitor Drug?
Todd Campbell, The Motley Fool - Motley Fool - Tue Aug 26, 10:41AM CDT
According to ViiV Healthcare -- GlaxoSmithKline , Pfizer , and Shionogi 's HIV drug consortium -- one in three Americans fails to take their HIV medication as prescribed. That means hundreds of thousands of patients aren't receiving the medicine...

Active Pharmaceutical Ingredients Global Market - Forecast to 2020
M2 - Tue Aug 26, 10:20AM CDT
Research and Markets (http://www.researchandmarkets.com/research/n53c3t/active) has announced the addition of the "Active Pharmaceutical Ingredients Global Market - Forecast to 2020" report to their offering. Active Pharmaceutical Ingredients (API) are active substances used in pharmaceutical drug product intended to achieve pharmacological activity or induce beneficial health effects by having direct effect on diagnosis, prevention or treatment of disease in human and other animals. API's are manufactured by chemical synthesis, fermentation, biotechnological methods or recovered from natural source. Active pharmaceutical ingredient is the important component of every formulated product of pharmaceutical industry and has enormous therapeutic application in the field of cancer, multiple myeloma, respiratory disorders and hormonal imbalance. These ingredients are used in cardiovascular and hematopoietic system, genito-urinary system and as anti-infectives Overall API market is expected to growth at a CAGR of more than 8.0% from 2014 to 2019. The factors such as expiry of patented drugs and shift towards the use of low cost API drugs due to economic recession are driving the growth of active pharmaceutical ingredients market. In addition, the rising adoption of high potent active pharmaceutical ingredients effective in targeted therapy is boosting the global API market growth. While the challenges faced by the market include transparency and increased market fragmentation. Globally North America accounts the largest share in the API market. Asia-Pacific is second largest followed by Europe. Asia is growing at a highest CAGR compared to North America followed by Europe. The key players of Active Pharmaceutical Ingredient market are Sandoz-Lek-Biochemie (Switzerland), GlaxoSmithKline Pharmaceuticals Limited (India), AstraZeneca plc (U.K.), Novartis AG (Switzerland), Pfizer, Inc. (U.S.) and F. Hoffmann-La Roche Ltd. (Switzerland). Key Topics Covered: 1. Executive Summary 2. Introduction 3. Market Analysis 4. Active Pharmaceuticals Ingredients by Synthesis 5. Active Pharmaceuticals Ingredients by Therapeutic Applications 6. Regional Market Analysis 7. Company Developments 8. Major Company Profiles - Albemarle Corporation - Aurobindo - Boehringer Ingelheim GmbH - Cambrex Corporatio - Dr. Reddy's Lab - Lonza Group - Lupin - Novartis - Ranbaxy Laboratories - Teva Active Pharmaceutical Industries Limited For more information visit http://www.researchandmarkets.com/research/n53c3t/active

Early Glance: Pharmaceuticals companies
AP - Tue Aug 26, 10:12AM CDT
NEW YORK (AP) — Shares of some top pharmaceuticals companies are mixed at 10 a.m.:

Pfizer (PFE) Breaks Through Resistance at $29.03
Comtex SmarTrend(R) - Tue Aug 26, 8:58AM CDT
Shares of Pfizer (NYSE FE) have bullishly opened above the pivot of $28.97 today and have reached the first resistance level of $29.03. Should the shares continue to rise, the resistance pivots of $29.15 and $29.33 will be of interest.

Pfizer And Merck To Collaborate On Study Evaluating Novel Anti-Cancer Combination Regimen
Business Wire - Tue Aug 26, 7:00AM CDT
Pfizer Inc. (NYSE FE) and Merck & Co. Inc. (NYSE:MRK), known as MSD outside the United States and Canada, through a subsidiary, announced today that they have entered into an agreement to explore the therapeutic potential of the combination of Pfizer's crizotinib (XALKORI(R)) with Merck's investigational anti-PD-1 antibody pembrolizumab, in a Phase 1b clinical study evaluating the safety and tolerability of the combination in patients with ALK-positive advanced or metastatic non-small cell lung cancer (NSCLC). The financial terms of the agreement were not disclosed.

MedTech Defies Sequestration, M&As Steal the Show - Industry Outlook
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 3:31AM CDT
MedTech Defies Sequestration, M&As Steal the Show - Industry Outlook

MedTech Defies Sequestration, M&As Steal the Show - Investment Ideas
Zacks Equity Research - Zacks Investment Research - Tue Aug 26, 3:31AM CDT
MedTech Defies Sequestration, M&As Steal the Show - Investment Ideas
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Workday’s EU Cloud Move Raises the Sovereignty Bar Again

Updated Category News Views 60

Europe’s sovereignty squeeze just got a lot more concrete for Workday. The company is taking its EU Sovereign Cloud beyond the usual data-residency talking points by planning an Ireland-based operating company, European leadership, and governance intended to keep decisions on the service and customer data inside Europe. For a platform sitting underneath payroll, HR...

Continue Reading
Precision Metal Forming Is Industry's Quiet Backbone

Updated Category News Views 20

A fraction of a millimeter can turn a perfectly good industrial part into an expensive headache. That unglamorous reality sits at the center of Michele Caulfield's discussion of precision metal forming for HelloNation, and it deserves more attention than it usually gets. Investors watching manufacturing tend to chase flashy automation headlines, big aerospace orders, or...

Continue Reading
MassMedia's Two PRSA Wins Put Campaign Strategy in Focus

Updated Category News Views 128

A pair of trophies is nice; the underlying work matters more. MassMedia picked up two honors at the 2026 PRSA Las Vegas Valley Chapter Pinnacle Awards, presented October 28 at Siena Golf Club. One was a Pinnacle Award in Community Relations for its Safe Teen Driving work with Sam & Ash Injury Law. The other was an Award of Excellence in Reputation and Brand Management for...

Continue Reading
A Decade of Giving: Light the World Initiative's Impact

Updated Category News Views 131

The Red Kiosk Revolution It's not every day that a church initiative pops up in global conversations, but here we are—ten years into the Light the World initiative by The Church of Jesus Christ of Latter-day Saints. What's interesting is how these little kiosks, like silent ambassadors, have become a staple in 145 spots this holiday season, spanning continents. Each...

Continue Reading
Autoliv's Omni Safety Award Is a Promising Early Signal

Updated Category News Views 68

Reclined car seats are becoming a real engineering headache, not some showroom gimmick, and Autoliv has put a marker down with Omni Safety™. The company received 2026 Automotive News PACE Pilot recognition for the system, which tackles occupant protection when people are sitting farther back than conventional vehicle safety designs assumed. That matters because...

Continue Reading
Workday GO for Financials Targets the Messy Middle

Updated Category News Views 146

Spreadsheets rarely die gracefully; they get buried under approvals, reconciliations, and the frantic scavenger hunt before an audit. Workday is aiming straight at that unpleasant moment with Workday GO for Financials, announced November 18 at Workday Rising EMEA in Barcelona. The pitch is not terribly romantic, thank goodness. It is a simpler way for growing companies to...

Continue Reading
Memorial Manor's Five-Star Signal in Long-Term Care

Updated Category News Views 130

Care quality is the only score that matters here A nursing home recognition is not the sort of news anybody should read like a trophy-case press release and then forget by lunch. Families make decisions around long-term care when they are tired, worried, and often dealing with a parent or spouse whose needs have changed fast. In that setting, a facility putting up both a...

Continue Reading
Benicia's Bold Move to Streamline Permitting Pays Off

Updated Category News Views 196

Award-Winning Innovation from Benicia Benicia, California, shoots ahead of the pack by scooping up a highly coveted Helen Putnam Award for Excellence. Why? They chopped down bureaucracy like a lumberjack with a new ax by ushering in a digital revolution for their permitting process. Make no mistake, folks, this ain’t just a pat on the back—it's a blueprint for cities...

Continue Reading
Snowhawk Enters Telarus as Digital Demand Gets Serious

Updated Category News Views 144

Telarus just pulled another serious capital partner into the room, and that matters more than the usual law-firm victory lap. Snowhawk Partners has invested in the technology services distributor alongside Columbia Capital, which remains a long-standing partner. Nobody disclosed a valuation, ownership percentage, financing mix, or closing date. Annoying? Sure. But the...

Continue Reading
Airtel Money Upgrade Raises the Stakes in East Africa

Updated Category News Views 54

Mobile money lives or dies in the irritating little moments: a transfer that hangs, a menu that makes people punch five buttons too many, a merchant payment that simply will not clear. Airtel Money is attacking that friction in Malawi and Tanzania with an enhanced platform from Comviva, and this is more consequential than the usual software-refresh chest thumping. In...

Continue Reading

Top 5 Most Recently Viewed Articles

Qubic's Game-Changing Milestone in Proof of Work Innovation

Updated Category News Views 335

Revolutionizing Mining: Qubic's Major Milestone Qubic, a decentralized compute and AI Layer 1 protocol, has reached a significant milestone with the successful implementation of its Useful Proof of Work (uPoW) concept. By harnessing the potential of merge mining with Monero and Tari, Qubic is setting a new standard in the mining industry and redefining the dynamics of...

Continue Reading
Global Ship Lease's Strong Q3 2024 Performance and Future Outlook

Updated Category News Views 187

Global Ship Lease Reports Impressive Third Quarter of 2024 Global Ship Lease, Inc. (NYSE: GSL), a key player in the containership ownership market, has recently revealed its unaudited financial results for the third quarter of 2024, reflecting strong operational performance and strategic positioning in an evolving maritime landscape. Quarterly Highlights: A Solid...

Continue Reading
Silverfort's New Security Features Enhance Identity Protection

Updated Category News Views 210

Enhancing Identity Security with Silverfort's New Capabilities Silverfort has recently announced exciting advancements in its identity security solutions, solidifying its leadership within the emerging identity verification and identity protection (IVIP) market. The introduction of Access Intelligence and Identity Graph & Inventory empowers organizations to proactively...

Continue Reading
Gabelli Multimedia Trust Maintains Steady Monthly Dividends

Updated Category News Views 306

Gabelli Multimedia Trust's Commitment to Shareholders The Gabelli Multimedia Trust Inc. (NYSE: GGT), located in RYE, N.Y., has reaffirmed its commitment to provide regular monthly cash distributions for its shareholders. This initiative emphasizes the Fund's dedication to maintaining a stable income stream, reflecting its solid financial strategies aimed at long-term...

Continue Reading
Shabodi Launches NetAware 2.1 to Transform Network Applications

Updated Category News Views 170

Shabodi Unveils NetAware 2.1: A Game-Changer for Programmable Networks Shabodi has proudly announced the launch of its innovative platform, NetAware 2.1, marking another significant stride in the realm of programmable networks. This advanced version embodies Shabodi's commitment to enhancing network-aware applications, offering a suite of capabilities that empower...

Continue Reading